Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OUCC AGM Information 2024

Jun 24, 2024

51893_rns_2024-06-24_c2c6f88e-c5a5-499c-b0a4-c4c014d3ceef.pdf

AGM Information

Open in viewer

Opens in your device viewer

==> picture [59 x 34] intentionally omitted <==

Oriental Union Chemical Corporation (OUCC)

2024 Annual Shareholders Meeting Minutes

Date: Wednesday, 12 June 2024

Time: 9:00 a.m. Taipei Time Place: Auditorium in the Taipei Hero House No. 20, Changsha Street, Section 1, Taipei, Taiwan

Convening Method:

Hybrid Shareholders Meeting (Physical Shareholders Meeting Supported by Video-Conferencing)

E-Meeting Platform:

Taiwan Depository & Clearing Corp./Stockvote Platform (https://www.stockvote.com.tw)

Shareholders present:

Total number of outstanding shares: 877,027,475 shares (excluding 8,675,554 shares owned by OUCC’s subsidiary)

Total shares represented by shareholders present: 513,063,375 shares (including shareholders attending via electronic and video conference)

Percentage of represented shares held by shareholders present: 58.50%

Directors present: Douglas Tong Hsu,

Representatives of Far Eastern New Century Corp.: Johnny Shih, Humphrey Cheng, Kao-Shan Wu

Representative of Yue Ming Trading Co., Ltd.: Justin Tsai

Representative of Da Chu Chemical Fiber Co., Ltd.: James Chou Representative of Yu Li Investment Co., Ltd.: Bing Shen

Independent Director & Convener of Audit Committee: Walt Cheng Independent Director: Ping Lih

Guests present: Peide P. Chen, CPA, Ming-Jiang Chen, Lawyer

Chairman: Douglas Tong Hsu, Chairman of the Board of Directors

==> picture [43 x 44] intentionally omitted <==

Recorder: Daniel Yu

==> picture [43 x 43] intentionally omitted <==

  • 1 -

Call the meeting to order

(The aggregate shares of shareholders present in person or by proxy constituted a quorum.)

Chairman’s remarks (Omitted)

A. Reporting items:

  1. 2023 Business Report (Omitted)

  2. 2023 Financial Statements (See attachment)

  3. Audit Committee’s review report of 2023 Business Report and Financial Statements (See attachment)

  4. 2023 Directors’ remuneration and employees’ compensation (Omitted)

B. Approval items:

1. To accept 2023 Business Report and Financial Statements

The Board of Directors proposes and recommends that each shareholder vote for the acceptance of 2023 Business Report and Financial Statements.

Explanatory notes:

  • i. OUCC’s 2023 Business Report and Financial Statements (including consolidated balance sheets, consolidated statements of comprehensive income, consolidated statements of changes in equity, consolidated statements of cash flows, and balance sheets, statements of comprehensive income, statements of changes in equity, statements of cash flows) have been audited by independent auditors, Hsin-Wei Tai and Li-Wen Kuo of Deloitte & Touche, and have been examined and determined to be correct and accurate by Audit Committee of OUCC. We thereby submit this report.

  • ii. Please accept the aforesaid Business Report and Financial Statements.

Voting Results: 513,134,143 shares were represented at the time of voting (including electronic and video voting); 501,258,971 shares voted for the proposal, representing 97.69% of the total represented shares, 3,750,344 shares voted against the proposal, while 8,124,828 shares voted abstained the proposal.

RESOLVED, that the 2023 Business Report and Financial Statements be and hereby accepted as submitted.

  • 2 -

2. To approve the proposal for the 2023 profit allocation

The Board of Directors proposes and recommends that each shareholder vote for the 2023 profit allocation.

Explanatory notes:

  • i. OUCC’s 2023 financial statement has been completed and audited by the CPAs of Deloitte & Touche. The 2023 profit allocation, pursuant to Article 34 of Articles of Incorporation, is proposed as follows: (Unit: NT$)

  • (A) Beginning of unappropriated earnings 33,273,245 (B) 2023 net income 265,724,314 (C) Confirmed reevaluated amount of welfare plan 2,940,018 for retained earnings

  • (D) Yearly net income with other item besides net 268,664,332 income included as unappropriated earnings (B)+(C)

  • (E) Legal reserve appropriation (26,866,433) (F) Retained earnings available for distribution (A)+(D)+(E) 275,071,144 (G) Shareholders dividend (NT$0.2/share in cash) (177,140,606) (H) Unappropriated earnings after distribution (F)+(G) 97,930,538

  • ii. After being approved at the 2024 Annual Shareholders Meeting, the cash dividend to common shareholders will be distributed on an ex-dividend date to be determined by the Board of Directors. Should OUCC subsequently repurchase its common shares or issue new common shares according to the relevant regulations, the total number of common shares outstanding may change, and the ultimate cash to be distributed to each common share may need to be adjusted accordingly. It is proposed that the Board of Directors of OUCC be authorized to adjust the cash to be distributed to each common share based on the total amount of profits resolved to be distributed and the number of actual common shares outstanding on the ex-dividend date for distribution.

  • iii. Please approve the aforesaid proposal.

Voting Results: 513,134,143 shares were represented at the time of voting (including electronic and video voting); 501,694,465 shares voted for the proposal, representing 97.77% of the total represented shares, 3,777,513 shares voted against the proposal, while 7,662,165 shares voted abstained the proposal.

RESOLVED, that the proposal for 2023 profit allocation be and hereby accepted as proposed.

  • 3 -

C. Discussion & election items

1. To elect the Board of Directors (including Independent Directors)

The Board of Directors proposes and recommends that each shareholder vote for the re-election of Directors (including Independent Directors).

Explanatory notes:

  • i. Upon the expiration of the Directors of the 16th term, the Board of Directors resolved to conduct the re-election at this annual general shareholders’ meeting.

  • ii. According to Article 16 and Article 17 of the Articles of Incorporation of the OUCC, eleven Directors (including three Independent Directors) shall serve the tenure of three years starting 12[th] June 2024.

  • iii. The re-election of Directors and Independent Directors are conducted according to the candidate nomination system, which allows the candidate to be nominated by Board of Directors or shareholders with shareholding over 1%. The nomination of Directors and Independent Directors starting 9 April till 18 April 2024, during which time OUCC acknowledged the nominated candidates of eight Directors and three Independent Directors from Far Eastern New Century Corporation, which nominees listed in the roster of candidates were submitted to the Board of Directors Meeting held at 30th April for approval. The candidates’ list is enclosed as attachment.

  • iv. Please approve the aforesaid election.

  • 4 -

Voting Results:

Voting Results:
Name Votes Received
Directors Douglas TongHsu 536,691,900
Far Eastern New Century Corporation
Representative: JohnnyShih
523,889,253
Far Eastern New Century Corporation
Representative: HumphreyCheng
520,117,952
Yue-Ming Trading Company
Representative: Justin Tsai
519,059,784
Far Eastern New Century Corporation
Representative: Kao-Shan Wu
492,041,147
Da Chu Chemical Fiber Co., Ltd.
Representative: Eric Chueh
480,907,592
Yu Li Investment Co., Ltd.
Representative: BingShen
474,070,479
Yu Li Investment Co., Ltd.
Representative: Alan Tsai
472,020,371
Independent
Directors
Walt Cheng 465,455,581
PingLih 461,673,225
An-MingWu 459,833,115
  • 5 -

2. To approve the release of the relevant Directors from the non-competitive restriction under Article 209 of the Company Act

The Board of Directors proposes and recommends that each shareholder vote for the release of the relevant Directors from the non-competitive restriction under Article 209 of the Company Act.

Explanatory notes:

  • i. According to Article 209-1 of Company Act “The Director who does anything for himself or on behalf of others that is within the scope of company business, shall explain the essential contents for such an act and obtain the approval from the Shareholders’ Meeting”.

  • ii. The newly elected Director of Oriental Union Chemical Corporation invests or operates as Director or Manager of another company which shares the same or similar business scope as the company, shall seek approval at the Shareholders’ Meeting to release new Directors and their representatives from the noncompetitive restriction.

iii. Please approve the release of the aforesaid non-competitive restriction.

Directors Served as Director/President of other company
in the industry
Douglas Tong Hsu Chairman, Oriental Petrochemical (Taiwan) Co., Ltd.
Director, Air Liquide Far Eastern
Far Eastern New Century Corporation
Representative: JohnnyShih
Director, Oriental Petrochemical (Taiwan) Co., Ltd.
and CTCI Corp.
Far Eastern New Century Corporation
Representative: Kao-Shan Wu
Director, Oriental Petrochemical (Taiwan) Co., Ltd.
Chairman, Far Eastern Union Petrochemical
(Yangzhou) Ltd.
Director, Far Eastern Industries (Shanghai) Ltd.
Yue-Ming Trading Company
Representative: Justin Tsai
Director, Oriental Petrochemical (Taiwan) Co., Ltd.,
Director, Far Eastern Union Petrochemical
(Yangzhou) Ltd.
Da Chu Chemical Fiber Co., Ltd.
Representative: Eric Chueh
Director & President, Oriental Petrochemical
(Taiwan) Co., Ltd.
Director, Far Eastern Union Petrochemical
(Yangzhou) Ltd.
Director, Far Eastern Industries (Shanghai) Ltd.
Yu Li Investment Co., Ltd.
Representative: Bing Shen
Independent Director, Elite Material Co., Ltd.
Director, ECOVE Environment Corp.
Independent Director, Far Eastern International
Bank
Yu Li Investment Co., Ltd.
Representative: Alan Tsai
Director, Far Eastern Union Petrochemical
(Yangzhou) Ltd.
Director, Far Eastern Industries (Shanghai) Ltd.
Walt Cheng Independent Director,TSEC Corporation
An-MingWu Independent Director,AHOKU Electronic Company
  • 6 -

Voting Results: 513,134,143 shares were represented at the time of voting (including e-voting); 471,716,228 shares voted for proposal, representing 91.93% of the total represented shares, 33,589,125 shares voted against the proposal, while 7,828,790 shares voted abstained the proposal.

RESOLVED, that the proposal for the release of the relevant Directors from the non-competitive restriction be and herby accepted as proposed.

D. Key points of shareholder’s speech: Nil

E. Extemporary Motion: Nil

F. Meeting Adjourned: by 09:53 am

  • 7 -

Attachment I

INDEPENDENT AUDITORS’ REPORT

The Board of Directors and Stockholders Oriental Union Chemical Corporation

Opinion

We have audited the accompanying consolidated financial statements of Oriental Union Chemical Corporation and its subsidiaries (the “Group”), which comprise the consolidated balance sheets as of December 31, 2023 and 2022, and the consolidated statements of comprehensive income, changes in equity and cash flows for the years then ended, and the notes to the consolidated financial statements, including a summary of material accounting policies (collectively referred to as the “consolidated financial statements”).

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of December 31, 2023 and 2022, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Financial Reporting Standards (“IFRS”), International Accounting Standards (“IAS”), IFRIC Interpretations (“IFRIC”), and SIC Interpretations (“SIC”) endorsed and issued into effect by the Financial Supervisory Commission (“FSC”) of the Republic of China (“ROC”).

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and the Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with The Norm of Professional Ethics for Certified Public Accountant of the ROC, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements for the year ended December 31, 2023. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

The descriptions of the key audit matters of the consolidated financial statements for the year ended December 31, 2023 are as follow:

The Impairment Loss of Property, Plant and Equipment

The consolidated balances of property, plant and equipment amounted to $11,378,230 thousand as of December 31, 2023. On each balance sheet date, the Group reviews its tangible assets for indications

  • 8 -

of impairment. If any indication thereof exists, the Group then estimates the recoverable amount of the assets. If it is not possible to determine the recoverable amount (fair value less cost to sell and value in use) for the individual asset, then the Group will determine the recoverable amount for the asset’s cash-generating unit. Because the aforementioned tangible assets represent 35% of total consolidated assets and the calculation for recoverable amount involves several assumptions and estimations, which directly impact the amount recognized as impairment losses, we deem the review of impairment of assets a key audit matter.

Corresponding audit procedures:

  1. We obtained an understanding of management’s estimation of asset impairment and of the design and execution for relevant controls.

  2. We evaluated the rationality of management’s identification of impairment indicators and the appropriateness of the assumptions. Given that there are impairment indications, we performed:

  3. a. Obtained the asset impairment valuation form produced by the management for each cashgenerating unit.

  4. b. Consulted Deloitte firm internal experts regarding the appropriateness of the assumptions, including the classification of cash-generating units, forecast of cash flows, and discount rate.

Other Matter

We have also audited the parent company only financial statements of Oriental Union Chemical Corporation as of and for the years ended December 31, 2023 and 2022 on which we have issued an unmodified report.

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and IFRS, IAS, IFRIC, and SIC endorsed and issued into effect by the FSC of the ROC, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the audit committee, are responsible for overseeing the Group’s financial reporting process.

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a

  • 9 -

guarantee that an audit conducted in accordance with the Standards on Auditing of the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with the Standards on Auditing of the Republic of China, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Group to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient and appropriate audit evidence regarding the financial information of entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision, and performance of the group audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

  • 10 -

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements for the year ended December 31, 2023 and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audits resulting in this independent auditors’ report are Hsin-Wei Tai and Li-Wen Kuo.

Deloitte & Touche Taipei, Taiwan Republic of China

March 1, 2024

Notice to Readers

The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the ROC and not those of any other jurisdictions. The standards, procedures and practices to audit such consolidated financial statements are those generally applied in the ROC.

For the convenience of readers, the independent auditors’ report and the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the ROC. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language independent auditors’ report and consolidated financial statements shall prevail.

  • 11 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS DECEMBER 31, 2023 AND 2022

(In Thousands of New Taiwan Dollars)

ASSETS
CURRENT ASSETS
Cash and cash equivalents

Financial assets at fair value through profit or loss
Financial assets at amortized cost
Notes receivable, net
Trade receivables, net
Trade receivables from related parties
Other receivables
Inventories
Prepayments for purchases
Other prepayments
Non-current assets held for sale
Other current assets

Total current assets

NON-CURRENT ASSETS
Financial assets at fair value through other comprehensive income
Financial assets at amortized cost
Investments accounted for using the equity method
Property, plant and equipment

Construction in progress
Right-of-use assets
Investment properties
Intangible assets
Deferred tax assets
Other non-current assets

Total non-current assets

TOTAL

LIABILITIES AND EQUITY
CURRENT LIABILITIES

Short-term borrowings

Short-term bills payable

Notes payable

Trade payables

Other payables

Other payables to related parties

Lease liabilities
Other current liabilities

Total current liabilities

NON-CURRENT LIABILITIES

Long-term borrowings

Deferred tax liabilities
Lease liabilities

Net defined benefit liabilities

Guarantee deposits
Other non-current liabilities

Total non-current liabilities

Total liabilities

EQUITY ATTRIBUTABLE TO OWNERS OF THE CORPORATION
Ordinary shares

Capital surplus

Retained earnings
Legal reserve

Special reserve

Unappropriated earnings

Total retained earnings

Other equity
Exchange differences on translating foreign operations

Unrealized loss on financial assets at fair value through other comprehensive income
Total other equity

Treasury shares

NON-CONTROLLING INTERESTS

Total equity

TOTAL
2023
Amount
%
$ 1,917,016
6
66,595
-
-
-
110,852
-
911,145
3
80,746
-
563,784
2
1,397,180
4
364,188
1
66,911
-
-
-

177,571

1


5,655,988
17

7,103,068
22
64,942
-
138,109
-
11,378,230
35
3,113,584
9
376,973
1
1,682,742
5
48,857
-
525,309
2

2,926,529

9

27,358,343
83

$ 33,014,331
100

$ 6,126,925
19

199,936
1

151,733
-

1,333,301
4

453,256
1

89,875
-
6,629
-

262,355

1


8,624,010
26


9,014,232
27
718,463
2

14,998
-

158,090
1
40,530
-

53,250

-


9,999,563
30

18,623,573
56


8,857,031
27


1,087,752

3


1,619,080
5

1,911,129
6

301,938

1


3,832,147
12


(545,606)
(2)

(1,324,205)

(4)


(1,869,811)

(6)


(124,373)

-


2,608,012

8

14,390,758
44

$ 33,014,331
100
2022



































Amount
%
$ 2,145,428
6

48,707
-

352,755
1

147,865
-

910,342
3

68,344
-

572,852
2

1,264,508
4

275,762
1

59,321
-

308,622
1

333,001

1

6,487,507
19

7,384,643
21

64,523
-

187,675
-
12,389,916
35

2,346,572
7

385,495
1

1,682,742
5

40,815
-

548,518
2

3,389,398
10
28,420,297
81
$ 34,907,804
100
$ 7,727,567
22

-
-

145,512
-

1,195,524
4

618,928
2

77,092
-

4,233
-

212,264

1

9,981,120
29

9,598,259
28

730,928
2

9,765
-

168,584
-

54,375
-

70,038

-
10,631,949
30
20,613,069
59

8,857,031
25

1,085,930

3

1,615,037
5

1,911,129
5

214,458

1

3,740,624
11

(477,924)
(2)

(1,090,401)

(3)

(1,568,325)

(5)

(124,373)

-

2,303,848

7
14,294,735
41
$ 34,907,804
100
  • 12 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OPERATING REVENUE
Sales revenue

Other operating revenue

Total operating revenue

OPERATING COST
Cost of goods sold

GROSS PROFIT (LOSS)

OPERATING EXPENSES
Selling and marketing expenses
General and administrative expenses
Research and development expenses
Expected credit loss (gain)

Total operating expenses

LOSS FROM OPERATIONS

NON-OPERATING INCOME AND EXPENSES
Interest income
Rental income
Dividend income
Other income
Gain (loss) on disposal of property, plant and
equipment
Gain on disposal of investments
Gain on disposal of non-current asset held for
sale
Foreign currency exchange gain
Gain (loss) on financial assets at fair value
through profit or loss
Interest expense
Other expenses
Share of loss of associates accounted for using
the equity method

Total non-operating income and expenses
2023
Amount
%
$ 20,792,927 100
24,004

-

20,816,931
100

20,480,005
98

336,926

2

530,363
3
277,035
1
209,604
1
402

-

1,017,404

5

(680,478)
(3)

40,222
-
33,631
-
67,886
-
50,015
-
4,352
-
-
-
743,178
4
16,629
-
3,254
-
(375,387) (2)
(52,320)
-
(47,357)

-

484,103

2
2022

































Amount
%
$ 22,036,389 100
44,710

-
22,081,099
100
22,136,114
100
(55,015)

-

646,613
3

263,738
1

193,876
1
(1,513)

-
1,102,714

5
(1,157,729)
(5)

40,732
-

39,554
-

83,019
-

49,600
-

(2,362)
-

1,093,973
5

-
-

16,318
-

(1,753)
-

(306,808) (1)

(55,342)
-
(574,220)
(3)
382,711

1

(Continued)

  • 13 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

LOSS BEFORE INCOME TAX

INCOME TAX EXPENSE

NET LOSS FOR THE YEAR

OTHER COMPREHENSIVE LOSS
Items that will not be reclassified subsequently
to profit or loss:
Remeasurement of defined benefit plans
Unrealized loss on investments in equity
instruments at fair value through other
comprehensive income
Income tax relating to items that will not be
reclassified subsequently to profit or loss
Items that may be reclassified subsequently to
profit or loss:
Exchange differences on translating the
financial statement of foreign operations

Other comprehensive loss for the year, net
of income tax

TOTAL COMPREHENSIVE LOSS FOR THE
YEAR

NET PROFIT (LOSS) ATTRIBUTED TO:
Owners of the Corporation

Non-controlling interests


TOTAL COMPREHENSIVE LOSS
ATTRIBUTED TO:
Owners of the Corporation

Non-controlling interests


EARNINGS PER SHARE
Basic
Diluted
2023
Amount
%
$ (196,375) (1)
27,923

-

(224,298)
(1)

3,675
-
(233,804) (1)
(735)
-
(92,832)
(1)

(323,696)
(2)

$ (547,994)
(3)

$ 265,724
1
(490,022)
(2)

$ (224,298)
(1)

$ (32,822)
-
(515,172)
(3)

$ (547,994)
(3)

$ 0.30
$ 0.30
2022

























Amount
%
$ (775,018) (4)
15,007

-
(790,025)
(4)

1,955
-

(363,519) (1)

(391)
-
67,003

-
(294,952)
(1)
$ (1,084,977)
(5)
$ 38,873
-
(828,898)
(4)
$ (790,025)
(4)
$ (305,003) (1)
(779,974)
(4)
$ (1,084,977)
(5)
$ 0.04
$ 0.04
$
$
$
$
$



(Concluded)

  • 14 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(In Thousands of New Taiwan Dollars)


BALANCE AT JANUARY 1, 2022

Legal reserve
Cash dividends distributed by the Corporation
Net profit (loss) for the year ended December 31, 2022
Other comprehensive income (loss) for the year ended
December 31, 2022

Total comprehensive income (loss) for the year ended
December 31, 2022

Change in capital surplus from dividends distributed to subsidiary
Changes in capital surplus from investments accounted for using
the equity method

BALANCE AT DECEMBER 31, 2022
Legal reserve
Cash dividends distributed by the Corporation
Net profit (loss) for the year ended December 31, 2023
Other comprehensive income (loss) for the year ended
December 31, 2023

Total comprehensive income (loss) for the year ended
December 31, 2023

Change in capital surplus from dividends distributed to subsidiary
Changes in ownership interests in subsidiaries

BALANCE AT DECEMBER 31, 2023
Equity A Equity A ttributable to Owners of the Corporation Other Equity
Exchange
Unrealized Loss
on Financial
Assets
Differences on
at Fair Value
Translating Through Other
Foreign
Operations
Comprehensive
Income
Treasury Shares
Non-controlling
Interests
$ (496,003) $ (726,882) $ (124,373) $ 3,083,822


-
-
-
-

-
-
-
-
-
-
-
(828,898)

18,079

(363,519)

-

48,924


18,079

(363,519)

-

(779,974)

-
-
-
-

-

-

-

-

(477,924) (1,090,401)
(124,373)
2,303,848


-
-
-
-

-
-
-
-
-
-
-
(490,022)

(67,682)

(233,804)

-

(25,150)


(67,682)

(233,804)

-

(515,172)

-
-
-
-

-

-

-

819,336

$ (545,606)
$ (1,324,205)
$ (124,373)
$ 2,608,012
Total Equity
$ 15,920,602
-
(619,992)

(790,025)

(294,952)
(1,084,977)
6,376

72,726
14,294,735
-
(177,141)

(224,298)

(323,696)

(547,994)
1,822

819,336
$ 14,390,758
Ordinary Shares
$ 8,857,031

-
-
-

-


-


-

-

8,857,031
-
-
-

-


-


-

-

$ 8,857,031
Capital Surplus Retained Earnings














i







Paid-in Capital
n Excess of Par
Value
Treasury Shares
$ 470,767
$ 373,329

-
-
-
-
-
-

-

-


-

-

-
6,376

-

-

470,767
379,705
-
-
-
-
-
-

-

-


-

-

-
1,822

-

-

$ 470,767
$ 381,527
Other
$ 162,732

-
-
-

-


-

-

72,726

235,458
-
-
-

-


-

-

-

$ 235,458








Legal Reserve Special Reserve
Unappropriated
Earnings
$ 1,526,813
$ 1,911,129
$ 882,237

88,224
-
(88,224)
-
-
(619,992)
-
-
38,873

-

-

1,564


-

-

40,437

-
-
-

-

-

-

1,615,037
1,911,129
214,458
4,043
-
(4,043)
-
-
(177,141)
-
-
265,724

-

-

2,940


-

-

268,664

-
-
-

-

-

-

$ 1,619,080
$ 1,911,129
$ 301,938
  • 15 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars)

CASH FLOWS FROM OPERATING ACTIVITIES
Loss before income tax

Adjustments:
Depreciation expenses

Amortization expenses
Expected credit loss (gain)
(Gain) loss on financial assets at fair value through profit or
loss, net
Interest expense
Interest income
Dividend income
Share of loss of associates accounted for using the equity
method
(Gain) loss on disposal of property, plant and equipment
Gain on disposal of non-current assets held for sale
Gain on disposal of inventories
Write-downs of inventories
Unrealized loss (gain) on foreign currency exchange
Changes in operating assets and liabilities
Financial assets at fair value through profit or loss
Notes receivable
Trade receivables
Trade receivables from related parties
Other receivables
Inventories
Prepayments
Other current assets
Notes payable
Trade payables
Other payables
Other current liabilities
Net defined benefit liabilities
Other non-current liabilities

Cash generated from (used in) operations
Interest received
Interest paid
Income tax (paid) received

Net cash generated from (used in) operating activities
2023
$ (196,375)
1,064,480
14,454
402
(3,254)
375,387
(40,222)
(67,886)
47,357
(4,352)
(743,178)
-
9,271
19,258
(14,634)
36,880
(1,072)
(12,402)
(1,705)
(152,482)
(96,292)
155,430
6,221
137,777
(118,337)
50,091
(6,819)
(16,788)

441,210
42,678
(425,636)
(23,249)

35,003
2022
$ (775,018)
1,082,425

13,674

(1,513)

1,753

306,808

(40,732)

(83,019)

574,220

2,362

-
(1,093,973)

8,156

(11,854)

10,983

75,090

93,073

44,238

(6,939)

140,994

(81,408)

(141,216)

145,512

(361,077)

(589,575)

(75,458)

(59,943)
16,041

(806,396)

41,137

(280,424)
83
(1,045,600)

(Continued)

  • 16 -

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of financial assets at fair value through other
comprehensive income

Proceeds from the capital reduction of financial assets at fair
value through other comprehensive income
Decrease in financial assets at amortized cost
Proceeds from disposal of non-current assets held for sale

Payments for property, plant and equipment
Proceeds from disposal of property, plant and equipment
Payments for intangible assets
Proceeds from disposal of intangible assets
Decrease (increase) in other non-current assets
Increase in construction in progress
Other dividends received

Net cash generated from (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
(Repayments of) proceeds from short-term borrowings

Proceeds from short-term bills payable
Proceeds from long-term borrowings

Repayments of long-term borrowings

(Decrease) increase in guarantee deposits
Repayment of the principal portion of lease liabilities
Dividends paid to owners of the Corporation
Changes in non-controlling interests

Net cash (used in) generated from financing activities

EFFECTS OF EXCHANGE RATE CHANGES ON THE
BALANCE OF CASH HELD IN FOREIGN CURRENCIES

NET (DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF
THE YEAR

CASH AND CASH EQUIVALENTS AT THE END OF THE
YEAR
2023
$ -
19,350
353,499
1,051,800
(26,737)
5,553
(17,415)
-
430,770
(886,920)
67,886

997,786

(1,503,384)
199,936
23,254,523
(23,838,259)
(13,845)
(5,340)
(175,319)
819,336

(1,262,352)

1,151

(228,412)
2,145,428

$ 1,917,016
2022
$ (573,959)

13,500

61,276

-

(19,519)

720

-

21

(422,808)
(1,119,339)
83,019
(1,977,089)
2,190,084

-
15,960,000
(14,491,139)

14,944

(10,284)

(613,616)
-
3,049,989
14,561

41,861
2,103,567
$ 2,145,428
(Concluded)
  • 17 -

INDEPENDENT AUDITORS’ REPORT

The Board of Directors and Stockholders Oriental Union Chemical Corporation

Opinion

We have audited the accompanying financial statements of Oriental Union Chemical Corporation (the “Corporation”), which comprise the balance sheets as of December 31, 2023 and 2022, and the statements of comprehensive income, changes in equity and cash flows for the years then ended, and notes to the financial statements, including material accounting policy information (collectively referred to as the “financial statements”).

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Corporation as of December 31, 2023 and 2022, and its financial performance and its cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and the Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Corporation in accordance with The Norm of Professional Ethics for Certified Public Accountant of the ROC, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matter

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements for the year ended December 31, 2023. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

The descriptions of the key audit matters of the financial statements for the year ended December 31, 2023 are as follow:

The Impairment Loss of Property, Plant and Equipment

The balances of property, plant and equipment amounted to $4,513,098 thousand as of December 31, 2023. On each balance sheet date, the Corporation reviews its tangible assets for indications of impairment. If any indication thereof exists, the Corporation then estimates the recoverable amount of the assets. If it is not possible to determine the recoverable amount (fair value less cost to sell and

  • 18 -

value in use) for the individual asset, then the Corporation will determine the recoverable amount for the asset’s cash-generating unit. Because the aforementioned tangible assets represent 20% of total assets and the calculation for recoverable amount involves several assumptions and estimations, which directly impact the amount recognized as impairment losses, we deem the review of impairment of assets a key audit matter.

Corresponding audit procedures:

  1. We obtained an understanding of management’s estimation of asset impairment and of the design and execution for relevant controls.

  2. We evaluated the rationality of management’s identification of impairment indicators and the appropriateness of the assumptions. Given that there are impairment indications, we performed:

  3. a. Obtained the asset impairment valuation form produced by the management for each cashgenerating unit.

  4. b. Consulted Deloitte firm internal experts regarding the appropriateness of the assumptions, including the classification of cash-generating units, forecast of cash flows, and discount rate.

Responsibilities of Management and Those Charged with Governance for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is responsible for assessing the Corporation’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Corporation or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the audit committee, are responsible for overseeing the Corporation’s financial reporting process.

Auditors’ Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Standards on Auditing of the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

  • 19 -

As part of an audit in accordance with the Standards on Auditing of the Republic of China we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Corporation’s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Corporation’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Corporation to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient and appropriate audit evidence regarding the financial information of entities or business activities within the Corporation to express an opinion on the financial statements. We are responsible for the direction, supervision, and performance of the Corporation audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

  • 20 -

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements for the year ended December 31, 2023 and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audits resulting in this independent auditors’ report are Hsin-Wei Tai and Li-Wen Kuo.

Deloitte & Touche Taipei, Taiwan Republic of China

March 1, 2024

Notice to Readers

The accompanying financial statements are intended only to present the financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the ROC and not those of any other jurisdictions. The standards, procedures and practices to audit such financial statements are those generally applied in the ROC.

For the convenience of readers, the independent auditors’ report and the accompanying financial statements have been translated into English from the original Chinese version prepared and used in the ROC. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language independent auditors’ report and financial statements shall prevail.

  • 21 -

ORIENTAL UNION CHEMICAL CORPORATION

BALANCE SHEETS

DECEMBER 31, 2023 AND 2022

(In Thousands of New Taiwan Dollars)

ASSETS
CURRENT ASSETS
Cash and cash equivalents

Notes receivable, net
Trade receivables, net
Trade receivables from related parties
Other receivables
Inventories
Prepayments for purchases
Other prepayments
Non-current assets held for sale
Other current assets

Total current assets

NON-CURRENT ASSETS
Financial assets at fair value through other comprehensive income
Financial assets at amortized cost
Investments accounted for using the equity method
Property, plant and equipment
Construction in progress
Right-of-use assets
Investment properties
Intangible assets
Deferred tax assets
Other non-current assets

Total non-current assets

TOTAL

LIABILITIES AND EQUITY

CURRENT LIABILITIES
Trade payables

Other payables
Lease liabilities

Other current liabilities


Total current liabilities


NON-CURRENT LIABILITIES
Long-term borrowings
Deferred tax liabilities
Lease liabilities

Net defined benefit liabilities

Guarantee deposits

Other non-current liabilities


Total non-current liabilities

Total liabilities


EQUITY

Ordinary shares

Capital surplus

Retained earnings

Legal reserve

Special reserve
Unappropriated earnings

Total retained earnings

Other equity

Exchange differences on translating foreign operations

Unrealized loss on financial assets at fair value through other comprehensive income

Total other equity

Treasury shares

Total equity

TOTAL
2023
Amount
%
$ 356,473
2
77,743
-
704,106
3
53,192
-
1,842
-
784,494
4
99,593
1
21,680
-
-
-
98,761

-

2,197,884
10

4,326,158 19
64,942
-
5,697,426 25
4,513,098 20
2,805,814 12
21,350
-
1,682,742
8
5,311
-
239,808
1
1,200,547

5

20,557,196
90

$ 22,755,080
100

$ 782,049
3
350,860
2

6,629
-
175,589

1


1,315,127

6


8,700,000
38
698,046
3

14,998
-

158,090
1

32,823
-
53,250

-


9,657,207
42

10,972,334
48


8,857,031
39

1,087,752

5


1,619,080
7
1,911,129
9
301,938

1

3,832,147
17


(545,606) (2)
(1,324,205)
(6)

(1,869,811)
(8)

(124,373)
(1)

11,782,746
52

$ 22,755,080
100
2022


































Amount
%
$ 344,876
2

55,704
-

646,029
3

66,724
-

331
-

656,156
3

9,011
-

17,377
-

308,622
1
185,275

1
2,290,105
10

3,920,805 17

64,523
-

6,320,201 28

4,948,718 22

2,232,242 10

14,046
-

1,682,742
7

6,941
-

258,129
1
1,180,387

5
20,628,734
90
$ 22,918,839
100
$ 494,261
2

301,589
1

4,233
-
122,857

1
922,940

4

8,999,258
39

708,247
3

9,765
-

168,584
1

49,120
-
70,038

1
10,005,012
44
10,927,952
48
8,857,031
39
1,085,930

5

1,615,037
7

1,911,129
8
214,458

1
3,740,624
16

(477,924) (2)
(1,090,401)
(5)
(1,568,325)
(7)
(124,373)
(1)
11,990,887
52
$ 22,918,839
100
  • 22 -

ORIENTAL UNION CHEMICAL CORPORATION

STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OPERATING REVENUE
Sales revenue

OPERATING COSTS
Cost of goods sold

GROSS PROFIT

OPERATING EXPENSES
Selling and marketing expenses
General and administrative expenses
Research and development expenses
Expected credit loss (gain)

Total operating expenses

PROFIT FROM OPERATIONS

NON-OPERATING INCOME AND EXPENSES
Interest income
Rental income
Dividend income
Other income
Gain (loss) on disposal of property, plant and
equipment
Gain on disposal of non-current assets held for
sale
Foreign currency exchange gain
Interest expense
Other expenses
Share of loss of subsidiaries accounted for using
equity method

Total non-operating income and expenses

PROFIT BEFORE INCOME TAX
INCOME TAX EXPENSE

NET PROFIT FOR THE YEAR
2023
Amount
%
$ 10,347,248 100
9,345,111
90

1,002,137
10

494,204
5
139,349
1
168,427
2
402

-

802,382

8

199,755

2

8,978
-
33,739
-
67,886
1
27,687
-
5,553
-
743,178
7
5,876
-
(147,455) (1)
(30,480)
-
(619,149)
(6)

95,813

1

295,568
3
29,844

-

265,724

3
2022
































Amount
%
$ 12,770,275 100
11,426,269
90
1,344,006
10

617,342
5

106,355
1

156,500
1
(1,513)

-
878,684

7
465,322

3

2,899
-

39,662
-

83,019
1

34,605
-

(1,314)
-

-
-

7,334
-

(78,666)
-

(33,256)
-
(463,590)
(4)
(409,307)
(3)

56,015
-
17,142

-
38,873

-

(Continued)

  • 23 -

ORIENTAL UNION CHEMICAL CORPORATION

STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OTHER COMPREHENSIVE LOSS
Items that will not be reclassified subsequently
to profit or loss:
Remeasurement of defined benefit plans

Unrealized loss on investments in equity
instruments at fair value through other
comprehensive income
Income tax relating to items that will not be
reclassified subsequently to profit or loss
Share of the other comprehensive loss of
subsidiaries accounted for using equity
method
Items that may be reclassified subsequently to
profit or loss:
Share of the other comprehensive income
(loss) of subsidiaries accounted for using
equity method

Other comprehensive loss for the year, net
of income tax

TOTAL COMPREHENSIVE LOSS FOR THE
YEAR

EARNINGS PER SHARE
Basic
Diluted
2023
Amount
%
$ 3,675
-
424,703
4

(735)
-
(658,507) (6)
(67,682)
(1)

(298,546)
(3)

$ (32,822)

-

$ 0.30
$ 0.30
2022










Amount
%
$ 1,955
-

(248,734) (2)

(391)
-

(114,785)
-
18,079

-
(343,876)
(2)
$ (305,003)
(2)
$ 0.04
$ 0.04
$


(Concluded)

  • 24 -

ORIENTAL UNION CHEMICAL CORPORATION

STATEMENTS OF CHANGES IN EQUITY FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 (In Thousands of New Taiwan Dollars)

BALANCE AT JANUARY 1, 2022

Legal reserve
Cash dividends distributed by the Corporation
Net profit for the year ended December 31, 2022
Other comprehensive income (loss) for the year ended
December 31, 2022

Total comprehensive income (loss) for the year ended
December 31, 2022

Change in capital surplus from dividends distributed to
subsidiary
Changes in capital surplus from investments accounted
for using the equity method

BALANCE AT DECEMBER 31, 2022
Legal Reserve
Cash dividends distributed by the Corporation
Net profit for the year ended December 31, 2023
Other comprehensive income (loss) for the year ended
December 31, 2023

Total comprehensive income (loss) for the year ended
December 31, 2023

Change in capital surplus from dividends distributed to
subsidiary

BALANCE AT DECEMBER 31, 2023
Ordinary
Shares
$ 8,857,031
-
-
-

-


-

-

-

8,857,031
-
-
-

-


-


-

$ 8,857,031
Capital Surplus
Retained Earnings
Other Equity
Exchange
Unrealized Loss
on Financial
Assets at Fair
Differences on Value Through
Translating
Other
Foreign
Operations
Comprehensive
Income
Treasury Shares
$ (496,003) $ (726,882) $ (124,373)

-
-
-

-
-
-

-
-
-

18,079

(363,519)

-


18,079

(363,519)

-


-
-
-

-

-

-


(477,924)
(1,090,401)
(124,373)

-
-
-

-
-
-

-
-
-

(67,682)

(233,804)

-


(67,682)

(233,804)

-


-

-

-

$ (545,606)
$ (1,324,205)
$ (124,373)
Total Equity
$ 12,836,780

-

(619,992)

38,873

(343,876)

(305,003)

6,376

72,726
11,990,887

-

(177,141)

265,724

(298,546)

(32,822)

1,822
$ 11,782,746

















i















Paid-in Capital
n Excess of Par
Value
Treasury Shares
$ 470,767 $ 373,329

-
-

-
-

-
-

-

-


-

-


-
6,376

-

-


470,767
379,705

-
-

-
-

-
-

-

-


-

-


-

1,822

$ 470,767
$ 381,527
Other
$ 162,732

-

-

-

-


-


-

72,726


235,458

-

-

-

-


-


-

$ 235,458
















Legal Reserve Special Reserve
Unappropriated
Earnings
$ 1,526,813 $ 1,911,129 $ 882,237

88,224
-
(88,224)

-
-
(619,992)

-
-
38,873

-

-

1,564


-

-

40,437


-
-
-

-

-

-


1,615,037
1,911,129
214,458

4,043
-
(4,043)

-
-
(177,141)

-
-
265,724

-

-

2,940


-

-

268,664


-

-

-

$ 1,619,080
$ 1,911,129
$ 301,938
  • 25 -

ORIENTAL UNION CHEMICAL CORPORATION

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(In Thousands of New Taiwan Dollars)

CASH FLOWS FROM OPERATING ACTIVITIES
Profit before income tax

Adjustments:
Depreciation expenses
Amortization expenses
Expected credit loss (gain)
Interest expense
Interest income
Dividend income
Share of loss of subsidiaries accounted for using equity method
(Gain) loss on disposal of property, plant and equipment
Gain on disposal of non-current assets held for sale
Write-downs of inventories
Unrealized loss (gain) on foreign currency exchange
Changes in operating assets and liabilities
Notes receivable
Trade receivables
Other receivables
Inventories
Prepayments
Other current assets
Trade payables
Other payables
Other current liabilities
Net defined benefit liabilities
Other non-current liabilities

Cash generated from operations
Interest received
Interest paid
Income tax (paid) received

Net cash generated from operating activities
2023
$ 295,568
530,787
7,491
402
147,455
(8,978)
(67,886)

619,149
(5,553)
(743,178)
27,023
372
(22,172)
(44,814)
(362)
(155,361)
(95,161)
86,514
287,788
21,745
52,732
(6,819)
(16,788)

909,954
8,892
(152,256)
(23,246)

743,344
2022
$ 56,015

538,401

7,950

(1,513)

78,666

(2,899)

(83,019)

463,590

1,314

-

18,337

(10,732)

21,640

230,433

85

(47,831)

2,307

(16,226)

(622,849)

(65,005)

(30,526)

(59,943)
16,041

494,236

2,829

(69,677)
83
427,471

(Continued)

  • 26 -

ORIENTAL UNION CHEMICAL CORPORATION

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(In Thousands of New Taiwan Dollars)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of financial assets at fair value through other
comprehensive income
Proceeds from the capital reduction of financial assets at fair
value through other comprehensive income
(Increase) decrease in financial assets at amortized cost
Acquisition of subsidiaries
Proceeds from disposal of non-current assets held for sale

Proceeds from disposal of property, plant and equipment
Increase in other non-current assets
Increase in construction in progress

Dividends received

Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from long-term borrowings

Repayments of long-term borrowings

(Decrease) increase in guarantee deposits
Repayment of the principal portion of lease liabilities
Dividends paid to owners of the Corporation

Net cash (used in) generated from financing activities

EFFECTS OF EXCHANGE RATE CHANGES ON THE
BALANCE OF CASH HELD IN FOREIGN CURRENCIES

NET INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF
THE YEAR

CASH AND CASH EQUIVALENTS AT THE END OF THE
YEAR
2023
-
19,350
(419)
(720,741)
1,051,800
5,553
(24,201)
$ (632,567)
67,886

(233,339)

21,490,000
(21,789,258)
(16,297)
(5,340)
(177,141)

(498,036)

(372)

11,597
344,876

$ 356,473
2022

(409,517)

13,500

22,694

-

-

720

(265,733)
$ (1,052,082)
83,019
(1,607,399)
13,100,000
(11,700,313)

13,737

(10,284)
(619,992)
783,148
10,732

(386,048)
730,924
$ 344,876

(Concluded)

  • 27 -

Attachment II

The Audit Committee’s Review Report

To the 2024 Annual Shareholders’ Meeting of Oriental Union Chemical Corporation,

In accordance with Article 14-4 of the Securities and Exchange Act and Article 219 of the Company Act, we have examined the Business Report, Financial Statements, and the Resolution for Allocation of Surplus Profit submitted by the Board of Directors for the year ending 2023, which have been audited by the CPAs, Hsin-Wei Tai and Li-Wen Kuo of Deloitte & Touche, and found them in order.

The Convener of the Audit Committee: Walt Cheng

==> picture [138 x 56] intentionally omitted <==

March 1, 2024

  • 28 -